Skip to main content

Advertisement

Table 2 Immunoreactivity of NKX2.2, PDX-1 and CDX-2 in 109 well-differentiated neuroendocrine tumors

From: NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors

Site Total = 109 NKX2.2 + PDX-1 + CDX-2 +
Rectum 16 16 (100%) 0 0
Colon 5 5 (100%) 0 3 (60%)
Appendix 22 22 (100%) 7 (32%) 22 (100%)
Ileum 12 11 (92%) 1 (8%) 12 (100%)
Jejunum 10 10 (100%) 2 (20%) 10 (100%)
Duodenum 4 4 (100%) 3 (75%) 3 (75%)
Stomach 12 2 (17%) 0 0
Pancreas 17 12 (71%) 1 (6%) 2 (11%)
Lung 11 0 0 0
Total GI-pancreas 98 82 (84%) 14 (14%) 52 (53%)
  1. Abbreviation: GI, gastrointestinal